SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 12 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,787,000 | +16.6% | 150,000 | 0.0% | 0.07% | +3.1% |
Q2 2018 | $1,532,000 | -21.3% | 150,000 | 0.0% | 0.06% | -29.7% |
Q1 2018 | $1,947,000 | +33.4% | 150,000 | 0.0% | 0.09% | +19.7% |
Q4 2017 | $1,460,000 | -33.9% | 150,000 | 0.0% | 0.08% | -39.2% |
Q3 2017 | $2,208,000 | -8.5% | 150,000 | 0.0% | 0.12% | -16.7% |
Q2 2017 | $2,414,000 | +1.0% | 150,000 | 0.0% | 0.15% | -5.1% |
Q1 2017 | $2,390,000 | +31.0% | 150,000 | 0.0% | 0.16% | +32.8% |
Q4 2016 | $1,824,000 | -12.3% | 150,000 | 0.0% | 0.12% | -6.3% |
Q3 2016 | $2,081,000 | -23.6% | 150,000 | 0.0% | 0.13% | -24.0% |
Q2 2016 | $2,723,000 | – | 150,000 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |